Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
34 /100
COMPONENT-LIMITED
Score updated Nov 21, 2026

ADRX — ADARx Pharmaceuticals, Inc. Dilution Risk Tracker

Track ADRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — higher scores indicate higher risk of share dilution.

Not financial advice. Do your own research before making any investment decisions.

Track ADRX — Get alerts when the score changes →

As of November 21, 2026, ADARx Pharmaceuticals, Inc. (ADRX) has a DilutionWatch DilutionScore of 34/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. ADARx Pharmaceuticals, Inc. has a market capitalization of $1.56B, 111.19M shares outstanding.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

Offering Ability
40
Cash Runway
0
Float Risk—
Warrant Exposure
40
Convertible Debt
40

Dilution Forecast

Forecast data not available for this ticker.

Market Data

Market Cap$1.56B
Shares Outstanding111.19M
FloatN/A
Cash$901.01M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore34/100DilutionWatch score record
Shares Outstanding111.19MVerified float table or market cache
Public FloatNot availableVerified float table or market cache
Market Cap$1.56BMarket data cache
Cash Runway105.7 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 3 3, 8-K 1, EFFECT 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

ADRX SEC Filing Activity — Last 12 Months

Shares outstanding reported by ADRX on the cover page of its latest 10-K/10-Q: 111.19M as of November 06, 2026.

DilutionWatch recorded no shelf, registration or prospectus documents for ADRX in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
8-Kcurrent report (material event)1Nov 12, 2026
10-Qquarterly report1Nov 12, 2026
SC 13Dactivist / >5% holder filing2Oct 05, 2026
SC 13Gpassive >5% holder filing3Nov 13, 2026
SC 13G/Aamended passive >5% holder filing1Nov 16, 2026
4insider transaction11Sep 30, 2026

Institutional Holdings

Institutional data not yet available.

Short Interest

Short Interest1.80M
Days to Cover5.0
% of FloatN/A
FINRA data as of Oct 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-11-12
8-K 8K EVENT 2026-09-28
3 FORM3 2026-09-24
EFFECT EFFECT 2026-09-24
3 FORM3 2026-09-24
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual ADRX Dilution Snapshot

ADARx Pharmaceuticals, Inc. (ADRX) has a DilutionScore of 34/100, rated Medium dilution risk. Score date: November 21, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ADRX's DilutionScore is currently 34/100 (Medium risk), with 1 score change tracked over 90 days. The score deteriorated from 40/100 (Medium risk).

Period Score Risk Level Duration
Nov 13 – Nov 21, 202634/100MEDIUM9 days
Aug 24 – Nov 12, 202640/100MEDIUM81 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track ADRX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ADRX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ADRX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 7,727+ tracked stocks →

Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note